A new technique is under development using CD8 PET imaging with the 89Zr-Df-IAB22M2C radioisotope to visualize the distribution of CD8+ T cells in the whole body or at tumor sites, and potentially to predict early tumor responses to immunotherapy [138]. Here, CD8A is linked to neoplasm.